Strong retail interest to persist in equity market despite moratorium expiry, says Rakuten
Rakuten's top picks: AHB, D'nonce and Scomnet:
Meanwhile, Rakuten Trade's top fundamentals picks are office furniture manufacturer AHB Holdings Bhd (target price (TP): 61 sen), engineering solutions provider D’nonce Technology Bhd (TP: 88 sen), and Supercomnet Technologies Bhd (Scomnet)(TP:RM2.68) — a manufacturer of wires and cable for medical devices, electrical appliance, consumer electronics and automotive markets.
All three stocks are deemed to be beneficiaries of the Covid-19 theme. For AHB, Rakuten said it is set to benefit from the introduction of its latest products, namely “Covid Panels” and “SpaceCom Medical Hubs” — products that are designed for the office space and medical hubs for Covid-19 prevention. The group is expected to achieve record earnings in its financial year ending Sept 2021 (FY21), according to Rakuten Trade.
Similarly, the research house expects D’nonce to achieve record earnings in FY21, as the group's packaging boxes are being used by major glove manufacturers including Top Glove Corp Bhd.
On stock selection, after correcting 17.6% from a 22M high of RM0.71 (3 Sep) to RM0.585 yesterday, DNONCE (Not-rated) will be attractive to bargain on any price weakness towards the 0.56 (uptrend line support) and RM0.53 (30D SMA) supports levels. To recap, DNONCE is a diversified engineering solutions provider with key customer base from: 1) Healthcare division mainly serving major glove producers based in Thailand (manufacture packaging boxes for major glove manufacturers and produce plastic products for medical use); 2) E
Anything below 0.6 is a no brainer buy imo. even at this price I would still buy, but my exposure to this stock is already very high so I want to manage my risk. very promising company. this is not a buy/sell call.
foresee growth in their revenue since the increased supply volume of boxes to glove sector, thus it is not to worry abt bad quarter result. however, there is need to know that they are just supplying boxes and they have other business sector as well, so dont expect it will jump rocket high, tp 0.70-0.80 would be reasonable compare to RHB tp of 0.90
Don't forget, that normal times dnonce is traded at 0.3-0.4 (refer pre covid prices). Now, performance has improved by 16x (!!) with new management and reorganisation... I dare not to set a TP. I see the performance is sustainable.
hi terence775, well, dnonce is not a big player in ems sector, but as long as its not dragging it, it should be fine. Dnonce just only caught my attention earlier(i more to technology stocks but got hit badly), so my understanding to this company background may not be as good as veteran like you. but current price (applicable to all shares) in the market currently shouldnt be compare to pre-covid pricing consider the hype in market in past 5 months. Anyhow, i agreed with you that setting tp is just a guideline, let it's performance do the talking. Good luck and happy trading :)
Still, nobody can predict share price. I don't mind holding this company longer. As long as it is performing well, with good profits... imo no reason to sell to chase hype.
If IB gave TP around 70-90, meaning the share price will only stay around 60 or lower for at least 1 quarter. If IB don gave higher TP, how they going to sell and let the ikan bilis makan r..
Well thats not 100% true. IB TP guideline is based on the current company business growth and foresee its price within a quarter or two. So its true that the TP will not reflect within a week or two. Patient investor can gain from it by holding, while goreng kaki will also join in to push the price together for short term profit, so price may volatile abit but then remain progressively uptrend based on company performance.
Those feeding to ikan bilis would be those shares that are losing money every quarter but yet share price keep shooting up..those are the one that ikan bilis like us should be aware and avoid.
Well, like terence said, this share is still good to hold. let's see how it goes in a week or two.
QR 3 of Topglove is around the corner.. as the main supplier of Top Glove, It will influence the share price of Dnonce as well.. Once again.. They will be MCO and only C19 related industries will survive..
@fundamentaler, yes Dnonce packaging at thailand supplier to Topglove and Sri Trang Argo.... who is Sri Trang Argo, STA is thailand biggest glove producer and also World Top 3 glove production...
Many warrants will continue to be exercised, as they are expiring soon. Warrant holders can decide either to exercise their warrants or throw it away.
Exercising warrants is good for the company as it provides a cash flow injection. At the same time, it does dilute the share base by up to 10% if all warrants are exercised. As long as the company knows how to use the money, conversion of warrants into mother share is something I view positively.
I agree with you Terence775 as warrants is expiring in November hence Dnonce for now is currently undervalue but so long as the fundamentals of the company is strong, it will reflect on its share price in near future. If i'm not mistaken there is still 30% left for the exercised of warrant, so it is expected for the price to remain floating at this range. On a side note, i'm just bored and want to tease a bit with the exercising of the warrants .... Exercise ar, during CMCO must stay healthy ! ^-^
Provider of packaging and polymer engineering solutions Dnonce Technology Berhad (Dnonce) is a Bursa Malaysia main-board listed company that provides packaging and polymer engineering solutions. Its products and services mainly cater to three main industries: i) healthcare (34% and 41% of 1QFY4/21 total revenue and operating profit, respectively), ii) electrical and electronic (E&E; 58% and 56% of 1QFY4/21 total revenue and operating profit), and iii) manufacturing (8% and 3% of 1QFY4/21 total revenue and operating profit). Direct beneficiary of strong global glove demand due to Covid-19 At the onset of Covid-19, glove makers is experiencing surge in glove demand, indirectly benefitting the entire rubber glove supply chain. This includes Dnonce, a key supplier of glove packaging boxes via its strategically located factory in Sadao, Thailand. Media reports (The Edge Markets) suggest that Dnonce currently commands a c.30% market share (sales volume) in Sadao, where many glove makers are located, i.e Top Glove (TOPG MK, Add, TP: RM10.00, CP: RM8.76) and Sri Trang Gloves (STGT TB, NR). Growing capacity to cater for expected increase in demand On the back of robust global glove demand, both TOPG and STGT have stated plans to expand their glove production capacities in Sadao, Thailand over the next few years. In order to capture an expected rise in demand of packaging materials, Dnonce stated plans to gradually increase its Sadao production capacity by 50% from end-CY20F onwards, as its plant is already running at full utilisation rate currently. Dnonce expects capacity growth in the healthcare segment to underpin its earnings growth for the next few years. Riding on a recovery in the E&E segment Owing to the current global digitalisation trend, there has been rising demand for ITrelated products and services. Dnonce plans to ride on this trend, leading to higher demand for its manufactured E&E products, such as printed circuit board (PCB) components and precision trays. In addition, Dnonce expects higher demand for its cleanroom and box build assembly services that focus on memory drives (surge in cloud computing services that require memory drivers to support data centres). Dnonce expects a turnaround with strong performance ahead In 1QFY4/21, Dnonce announced a positive net profit of RM3.8m (>100% qoq and yoy), post two consecutive quarter of losses. While it is currently trading at a trailing 12-month P/E of 30.1x, Dnonce is of the view that the worst is over, and expects stronger results going forward, backed by: i) strong demand for glove packaging boxes, ii) capacity expansion plans in the glove packaging business, iii) recovery in the E&E segment, and iv) ongoing cost control measures.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
thestockoracle
391 posts
Posted by thestockoracle > 2020-09-15 11:12 | Report Abuse
people like to buy stocks when they are expensive. when it is selling at bargain price, they just ignore kao kao...